Physician

Mary Louise Kerber, MD

According to 2025 Medicare claims, Mary Kerber, MD (NPI: 1790768760) practices neurology in the Cheyenne, WY market, with the plurality of this provider's patient population coming from Laramie, WY. This provider's primary affiliated billing organization is POUDRE VALLEY MEDICAL GROUP, LLC (NPI: 1366763260; TIN: 800348943) and primary practice location at 82009-4800. Kerber is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Kerber's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 379 traditional Medicare patients, billed 11,334 HCPCS/CPT codes, and received $131,855 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,714 prescription claims across 367 beneficiaries totaling $967,917 in drug costs, led by Epidiolex (Cannabidiol (Cbd)). DME data shows 75 claims. Open Payments data shows 9 records totaling $911. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $365,061 to $131,855. Similarly, Part D prescription costs have declined steadily, from $1,732,605 to $967,917. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $68,934 and ending at $59,160.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	649	25,152	$365,061
2016	650	27,131	$376,128
2017	673	29,598	$408,838
2018	713	27,104	$390,658
2019	698	24,267	$370,814
2020	657	21,059	$312,606
2021	637	20,237	$328,171
2022	582	18,247	$248,149
2023	409	11,112	$138,829
2024	379	11,334	$131,855

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	374	5,049	$1,732,605
2016	392	4,978	$1,532,124
2017	402	4,748	$1,654,052
2018	375	4,608	$1,823,095
2019	420	5,064	$1,822,417
2020	433	5,079	$1,877,363
2021	432	5,153	$1,668,438
2022	454	5,187	$1,200,524
2023	392	4,774	$1,101,374
2024	367	4,714	$967,917

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	19	103	$14,187
2016	14	132	$9,757
2017	14	101	$5,392
2018	16	103	$5,422
2019	N/R	40	$2,168
2020	N/R	58	$4,649
2021	N/R	46	$4,299
2022	N/R	112	$10,859
2023	N/R	60	$4,891
2024	N/R	75	$4,420

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	161	257	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	200	269	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	113	139	$57
36415	Insertion of needle into vein for collection of blood sample	94	120	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	36	41	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Epidiolex	Cannabidiol (Cbd)	42	1,354	$195,762
Betaseron	Interferon Beta-1b	13	364	$121,335
Avonex Pen (4 Pack)	Interferon Beta-1a	12	336	$97,599
Kesimpta Pen	Ofatumumab	11	330	$93,423
Copaxone	Glatiramer Acetate	12	336	$68,495

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	59	$4,149
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	16	$272

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$911	LivaNova USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mary Louise Kerber, MD?

Tedicare shows public-source Medicare data for Mary Louise Kerber, MD (NPI 1790768760), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mary Louise Kerber, MD have ACO affiliation data?

Mary Louise Kerber, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Mary Louise Kerber, MD?

Mary Louise Kerber, MD is linked to POUDRE VALLEY MEDICAL GROUP, LLC (billing NPI 1366763260) in the available physician profile data.

Does Mary Louise Kerber, MD have Open Payments data?

Mary Louise Kerber, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.